Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Long-Term Debt Repayments (2022 - 2023)

bioAffinity Technologies (BIAF) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $42334.0 as the latest value for Q3 2023.

  • Quarterly Long-Term Debt Repayments rose 161.9% to $42334.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $576746.0 through Sep 2023, changed N/A year-over-year, with the annual reading at $425000.0 for FY2022, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q3 2023 was $42334.0 at bioAffinity Technologies, down from $126096.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $325000.0 in Q4 2022, with the low at -$68388.0 in Q3 2022.